Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
ClinicalTrials.gov study NCT02460146. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer
ClinicalTrials.gov study NCT05645692. IPD Sharing: YES. Countries: 15. Publications: 0.
Surufatinib Alone or Combined With Anti-PD-1 mAb in the Treatment of Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05282433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer
ClinicalTrials.gov study NCT05732948. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor
ClinicalTrials.gov study NCT04282278. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients
ClinicalTrials.gov study NCT04465890. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration
ClinicalTrials.gov study NCT03011996. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
ClinicalTrials.gov study NCT07277439. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
ClinicalTrials.gov study NCT07183865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
ClinicalTrials.gov study NCT03907826. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants
ClinicalTrials.gov study NCT04231513. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced Malignancies
ClinicalTrials.gov study NCT05577182. IPD Sharing: NO. Countries: 4. Publications: 0.
Lu AF28996 in Participants With Parkinson's Disease (PD)
ClinicalTrials.gov study NCT04291859. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)
ClinicalTrials.gov study NCT03210246. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
ClinicalTrials.gov study NCT00607451. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens
ClinicalTrials.gov study NCT03092739. IPD Sharing: NO. Countries: 6. Publications: 0.
Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne
ClinicalTrials.gov study NCT06989840. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X Allele
ClinicalTrials.gov study NCT04126473. IPD Sharing: Not stated. Countries: 3. Publications: 0.
PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC
ClinicalTrials.gov study NCT06396637. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy
ClinicalTrials.gov study NCT05581719. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.